Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
September 18, 2008

Crucell Obtains $2.5M from Talecris in Manufacturing Collaboration

  • Talecris Biotherapeutics is employing Crucell to produce a protein for $2.5 million. Under the terms of the exclusive, commercial license agreement, Crucell could earno roughly $30 million in milestone fees related to the protein across multiple indications. Crucell will use its PER.C6® cell line.
  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.